BioSpace News Archive

Intergalactic Therapeutics announced today that Gayathri Ramaswamy, Ph.D., Vice President, Drug Discovery and Disease Biology, will present at the Annual Retinal Cell and Gene Therapy Innovation Summit on April 21, 2023 at the Marriott New Orleans Warehouse Arts District in New Orleans, Louisiana.

Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced multiple presentations featuring positive efficacy and safety data from a Phase 2b study of the company’s lead drug candidate, AZR-MD-001, in Meibomian Gland Dysfunction (MGD).

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that four posters in Rett syndrome will be presented at the upcoming American Academy of Neurology (AAN) annual meeting, being held April 22 – 27, 2023 in Boston, Mass.

GE HealthCare (Nasdaq: GEHC) today announced US FDA 510(k) clearance of its CARESCAPE Canvas patient monitoring platform for precise, flexible patient care.

Therapeutic Solutions International (TSOI) announced today filing of a new Phase III clinical trial application with the FDA for use of its JadiCell adult stem cells in treatment of acute respiratory distress syndrome (ARDS).